Cryoport (CYRX) Cash & Equivalents (2016 - 2025)
Cryoport (CYRX) has disclosed Cash & Equivalents for 16 consecutive years, with $250.5 million as the latest value for Q4 2025.
- Quarterly Cash & Equivalents rose 453.1% to $250.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $250.5 million through Dec 2025, up 453.1% year-over-year, with the annual reading at $250.5 million for FY2025, 453.1% up from the prior year.
- Cash & Equivalents for Q4 2025 was $250.5 million at Cryoport, down from $255.8 million in the prior quarter.
- The five-year high for Cash & Equivalents was $353.2 million in Q1 2021, with the low at $28.8 million in Q2 2022.
- Average Cash & Equivalents over 5 years is $97.2 million, with a median of $42.3 million recorded in 2024.
- The sharpest move saw Cash & Equivalents crashed 91.77% in 2022, then surged 715.57% in 2025.
- Over 5 years, Cash & Equivalents stood at $139.1 million in 2021, then plummeted by 78.98% to $29.2 million in 2022, then soared by 58.54% to $46.3 million in 2023, then fell by 2.28% to $45.3 million in 2024, then skyrocketed by 453.1% to $250.5 million in 2025.
- According to Business Quant data, Cash & Equivalents over the past three periods came in at $250.5 million, $255.8 million, and $38.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.